ReviewJournal of cellular and molecular medicine2024

Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.

Mohammed Alrouji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.